Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / delaware-mae-case-law-survey.docx
delaware-mae-case-law-survey.docx
Parties
Penterra Pharmaceuticals Corp
Huntsman Corp
Fenmore Partners LLC
Frontier Oil Corp
Holly Corp
Brundavel Corp
Boston Scientific Corp
Greaves Corp
Dates
August 27, 2024
August 14, 2024
August 22, 2024
June 10, 2024
December 10, 2024
September 6, 2024
September 13, 2024
December 7, 2018
Amounts
$900,000,000
$420
$900
$3.2
$10.6
$4.75
$5.8
Obligations
The bring-down is qualified to the Material Adverse Effect standard — that is, the representations and warranties need not be literally true in every particular, but any inaccuracies must not, individually or in the aggregate, constitute a Material Adverse Effect
This condition provides that, since the date of the Agreement (June 10, 2024), no Material Adverse Effect shall have occurred that is continuing as of the Closing Date
The buyer must demonstrate, by a preponderance of the evidence, that the facts satisfy each element of the contractual MAE definition
For a target with no revenue and no current earnings, the concept of a "decline in earnings potential" must be adapted to focus on the impairment of expected future value derived from the company's pipeline
Instead, the analysis must focus on the impairment of expected future value derived from the pipeline
An MAE must be measured against the long-term value of the target, not against quarterly or annual fluctuations